Batavia Biosciences and Valneva Collaborate to Accelerate Development of Low-cost Inactivated Polio Vaccine

NEXT STORY
Immunicum AB (publ) Announces Advancement to a Non-Staggered Inclusion Phase in the Phase Ib/II ILIAD Combination Trial
PREV STORY
Hua Medicine’s Dorzagliatin Demonstrates Improvements in β-Cell Function in Data Presented at the American Diabetes Association’s 80th Scientific Sessions
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Batavia Biosciences and Valneva Collaborate to Accelerate Development of Low-cost Inactivated Polio Vaccine

NEXT STORY
Immunicum AB (publ) Announces Advancement to a Non-Staggered Inclusion Phase in the Phase Ib/II ILIAD Combination Trial
PREV STORY
Hua Medicine’s Dorzagliatin Demonstrates Improvements in β-Cell Function in Data Presented at the American Diabetes Association’s 80th Scientific Sessions
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Surgical Care Affiliates Partners With The Surgery Center at Doral

DEERFIELD, Ill., Dec. 12, 2016 (GLOBE NEWSWIRE) -- Surgical Care Affiliates, Inc. (NASDAQ:SCAI) (“SCA”), ...

author_avatar
NASDAQ Market News

Incysus Announces Appointment of Joy Bessenger as Senior Vice President, Finance and Strategy

NEW YORK, May 14, 2018 (GLOBE NEWSWIRE) -- Incysus Therapeutics, Inc., a biopharmaceutical company ...

author_avatar
NASDAQ Market News

Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2021 Financial Results

author_avatar
NASDAQ Market News